Medtronic Raised Its Fiscal Year 2025 Adjusted EPS Guidance To $5.42-$5.50 Versus The Prior Range Of $5.40-$5.50 And Consensus Of $5.44
Portfolio Pulse from Benzinga Newsdesk
Medtronic has raised its fiscal year 2025 adjusted EPS guidance to a range of $5.42-$5.50, slightly above the previous range and consensus estimates.
August 20, 2024 | 10:49 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Medtronic has increased its fiscal year 2025 adjusted EPS guidance to $5.42-$5.50, which is slightly above the previous range and consensus estimates. This indicates a positive outlook for the company's earnings.
The increase in EPS guidance suggests that Medtronic expects better financial performance than previously anticipated. This is likely to positively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100